title: Clinical use of recombinant human TSH in thyroid cancer patients.
abstract: Recombinant human TSH (rhTSH) is an effective and safe alternative to thyroid hormone withdrawal during the post-surgical follow-up of papillary and follicular thyroid cancer. Its clinical efficiency for the detection of persistent and recurrent disease is similar to that of thyroid hormone withdrawal. The main purpose for its use is to avoid hypothyroidism.
authors.affiliation: Department of Nuclear Medicine and Endocrine Tumors, Institut Gustave Roussy, 94805 Villejuif, Cèdex France. schlumbg@igr.fr
authors.forename: M
authors.initials: M
authors.lastname: Schlumberger
authors.forename: M
authors.initials: M
authors.lastname: Ricard
authors.forename: F
authors.initials: F
authors.lastname: Pacini
mesh_terms: D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000188:drug therapy*; D013972:Thyrotropin / Q000627:therapeutic use*
chemical_list: D011994:Recombinant Proteins; D013972:Thyrotropin